Loghman Pharmaceuticals
![]()  | |
| Company type | Public | 
|---|---|
| TSE: DLGM1 ISIN: IRO1DLGM0000  | |
| Industry | |
| Founded | 1968 | 
| Headquarters | Tehran, Iran | 
Area served  | Worldwide | 
Key people  | Khosro Davari, chief executive officer Alireza Zohrevand, Chairman  | 
| Products | Pharmaceutical drug Ampoule, Tablet (pharmacy), Capsule (pharmacy)  | 
| Total assets | |
| Website | www.loghmanpharma.com | 
Loghman Pharmaceutical & Hygienic Co. (Persian: شرکت دارویی و بهداشتی لقمان, Shirkat-e Darvii-ye vâ Behedashiti-ye Laqman) is an Iranian pharmaceuticals company. The company engages in the discovery, development, manufacture, and marketing of drugs in Iran.[1]
History
Loghmans was established in 1968 as I.D.I. Pharmaceuticals. In 1979, the company changed its name to Loghman and expanded its operations.[2]
The company has been listed on the Tehran Stock Exchange since 1997.[3]
products
- Acetaminophen+Codeine
 - Amoxicillin
 - Azithromycin
 - Buspirone
 - Carbamazepine
 - Cefalexin
 - Cefazolin
 - Cefepime
 - Cefixime
 - Ceftazidime
 - Ceftriaxone
 - Cefuroxime
 - Cefalexin
 - Diazepam
 - Erythromycin
 - Fluconazole
 - Sodium Fluoride
 - Ibuprofen
 - Indomethacin
 - Lorazepam
 - Losartan Potassium
 - Meropenem
 - Methimazole
 - Nortriptyline
 - Phenytoin
 - Sodium Fluoride
 - Sorbitol
 - Valsartan
 
Development plan
See also
References
- ^ "Stocks". Archived from the original on October 5, 2012.
 - ^ "شرکت دارویی بهداشتی لقمان". Archived from the original on 2013-07-08. Retrieved 2013-06-08.
 - ^ "Dlgm1 37,480".
 
.png)